| Ytd | -46.53% | |
| 1y | 366.73% |
| Open | 46.69 | Prev Close | 46.87 | Low | 45.61 | High | 47.00 | Mkt Cap | 63.80M |
| Vol | 916.00 | Avg Vol | 65.14K | EPS | -36.60 | P/E | -1.27 | Forward P/E | -0.41 |
| Beta | 3.23 | Short Ratio | 0.10 | Inst. Own | 46.69% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-15 | 50-d Avg | 48.50 | 200-d Avg | 69.88 | 1yr Est | 1.83 |
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Spruce Biosciences, Inc. (“Spruce Biosciences” or “Spr
B. Riley Securities analyst Madison El-Saadi initiates coverage on Spruce Biosciences (NASDAQ:SPR
Amazon Inc (NASDAQ: AMZN) rose in pre-market trading after announcing a strategic collaboration with
On Tuesday, 838 companies hit new 52-week lows.
On Friday, 1043 companies hit new 52-week lows.